Rosiglitazone attenuates indoxyl sulphate-induced endothelial dysfunction.

about

Vasculopathy in the setting of cardiorenal syndrome: roles of protein-bound uremic toxins.Indoxyl sulfate enhances IL-1β-induced E-selectin expression in endothelial cells in acute kidney injury by the ROS/MAPKs/NFκB/AP-1 pathway.

P2860

Q39243739-F43B99F3-4202-416F-A770-18E413246A6F Q46624915-ED6D73E6-8569-4E6F-9FA2-0C7F224E18F7

P2860

Rosiglitazone attenuates indoxyl sulphate-induced endothelial dysfunction.

Item

http://www.wikidata.org/entity/Q53674702

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Rosiglitazone attenuates indoxyl sulphate-induced endothelial dysfunction.

@en

Rosiglitazone attenuates indoxyl sulphate-induced endothelial dysfunction.

@nl

type

Item

label

Rosiglitazone attenuates indoxyl sulphate-induced endothelial dysfunction.

@en

Rosiglitazone attenuates indoxyl sulphate-induced endothelial dysfunction.

@nl

prefLabel

Rosiglitazone attenuates indoxyl sulphate-induced endothelial dysfunction.

@en

Rosiglitazone attenuates indoxyl sulphate-induced endothelial dysfunction.

@nl

P1476

Rosiglitazone attenuates indoxyl sulphate-induced endothelial dysfunction.

@en

P2093

Chia-An Chou

http://www.w3.org/2001/XMLSchema#string

Chien-Te Lee

http://www.w3.org/2001/XMLSchema#string

Hwee-Yeong Ng

http://www.w3.org/2001/XMLSchema#string

Lung-Chih Li

http://www.w3.org/2001/XMLSchema#string

Sung-Nan Pei

http://www.w3.org/2001/XMLSchema#string

Ting-Yu Terry Chiou

http://www.w3.org/2001/XMLSchema#string

Wei-Hung Kuo

http://www.w3.org/2001/XMLSchema#string

Yueh-Ting Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease

Cardiorenal syndrome: the emerging role of protein-bound uremic toxins

PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

The PPARs: from orphan receptors to drug discovery

Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectin

Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress

A bench to bedside view of uremic toxins.

Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.

Role of nuclear factor kappaB in cardiovascular health and disease.

P304

287-292

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1440-1681.12351

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25482161

http://www.w3.org/2001/XMLSchema#string

Rosiglitazone attenuates indoxyl sulphate-induced endothelial dysfunction.

about

P2860

P2860

Rosiglitazone attenuates indoxyl sulphate-induced endothelial dysfunction.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698